ALKEM LABORATORIES
|
The Current P/E Ratio of ALKEM LABORATORIES is 28.03.
| Share Price | ₹5,652.3 | Jan 06,2026 |
| Market Cap | ₹67,600.9 Cr | |
| Earnings-TTM | ₹2,411.7 Cr | TTM-Consolidated Results |
| Price/Earnings | 28.03x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ALKEM LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹67,600.9 Cr] as on Jan 06,2026
(/) Earnings [ ₹2,411.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 28.03x ]
Thus, for ALKEM LABORATORIES , the investors are currently willing to pay 28.03 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALKEM LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALKEM LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ALKEM LABORATORIES
PE Ratio Performance Analysis for ALKEM LABORATORIES
- ALKEM LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 29.66x.
- ALKEM LABORATORIES 's operated at median p/e ratio of 26.94x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALKEM LABORATORIES 's p/e ratio peaked in Mar2023 at 41.27x.
- ALKEM LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 20.91x.
How does ALKEM LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ALKEM LABORATORIES | 2,411.72 | 28.03 | 67,600.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 40.15 | 422,319.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 70.98 | 176,383.0 |
| CIPLA LTD | 5,453.86 | 22.67 | 123,617.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 62.26 | 133,241.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.32 | 104,825.0 |
| MANKIND PHARMA LTD | 1,767.06 | 52.37 | 92,544.7 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.84 | 93,705.5 |
| LUPIN LTD | 4,347.53 | 22.61 | 98,300.8 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.75 | 71,537.3 |
| ABBOTT INDIA LTD | 1,508.95 | 40.04 | 60,411.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALKEM LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.32x |
| Max industry PE | 70.98x |
| Median industry PE | 28.03x |
| Average industry PE | 36.09x |
You may also like the below Video Courses